Ovarian cancer life expectancy increased by abdomen injections
Chemotherapy injected directly into the abdomen could lead to three years being added to the average life expectancy of some ovarian cancer patients, according to new research.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units